
PolyPid rose 67.8% from $3.76 to a 1-year high of $6.31, ahead of the S&P 500's +9.8%. Its worst day was Jul 21 (−27.4%), and its low came Nov 13 at $3.58.
Story events cover the past 12 months · Times ET
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.37 beat the $-0.53 estimate on $0.00 revenue.
−0.3% · S&P 500 +0.1%
EPS of $-0.41 missed the $-0.33 estimate on $0.00 revenue.
−1.3% · S&P 500 0.0%
EPS of $-0.35 beat the $-0.44 estimate on $0.00 revenue.
−7.5% · S&P 500 +0.6%
PolyPid shares rose 11.2%, while the S&P 500 rose 0.9%.
+11.2%, the year's best day · S&P 500 +0.9%
PolyPid shares fell 27.4%, while the S&P 500 rose 0.8%.
−27.4%, the year's worst day, on 2M shares, the year's heaviest volume · S&P 500 +0.8%
EPS of $-0.35 beat the $-0.37 estimate on $0.00 revenue.
+2.3% · S&P 500 +0.3%
PolyPid shares rose 9.1%, while the S&P 500 rose 0.6%.
+9.1% · S&P 500 +0.6%
Where it ended: a 1-year high close of $6.31 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 11, 2026 (EPS est. $0.40, revenue est. $20.4M).
Nothing in the past 12 months.
All PYPD dividend history